Cleveland Clinic has used endoscopic submucosal dissection since 2013 to treat patients with early-stage gastric and esophageal tumors. Dr. Bhatt, who introduced the technique to the health system, discusses its evolution, clinical application, and the results of new outcomes research.
A new study presented at ACG 2018 helps make the argument for ESD en-bloc resection of high-risk polyps. It shows that with a select patient population, this type of resection may be truly beneficial and worth the extra effort. Dr. Amit Bhatt explains.
Unable to be operated on at her local hospital, a 59-year-old with a 7 cm esophageal squamous cell cancer undergoes ESD and remains cancer-free.
Gallstones are common in the United States, affecting an estimated 1 in 7 adults. Fortunately, they are asymptomatic in up to 80% of cases, and current guidelines do not recommend cholecystectomy unless they cause symptoms.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
An in-depth look at the current indications for endoscopic submucosal dissection in the evaluation and treatment of patients with early gastrointestinal neoplasms.
A surprising rise in gastric cancer among FAP patients caused physicians to change their surveillance techniques.
A new study investigates the relationship between bariatric surgery and changes in bile duct diameter. Amit Bhatt, MD, explains the findings.
A look at why hydroxyethyl starch is the best pick of seven common fluids used as injectate during ESD in the U.S. Dr. Amit Bhatt explains the findings.
Endoscopic submucosal dissection, a technique pioneered in Japan, is offering a less invasive alternative to surgery for patients with early gastrointestinal tumors.